BioCentury
ARTICLE | Clinical News

Vasogen preclinical data

November 1, 2004 8:00 AM UTC

In a rat model of cognitive dysfunction, VP025 reversed the impairment in long term potentiation and prevented effects of beta-amyloid. Also, VP025 decreased microglial cell activation and concentrat...